What are the possible diagnoses for a 58-year-old man with hypertension, hypothyroidism, and benign prostatic hyperplasia who presents with headaches, back pain, a hat that no longer fits, thickened calvarium, and mixed osteoblastic/osteolytic skull lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis

The primary diagnosis to consider is Paget's disease of bone, given the classic presentation of skull involvement with thickened calvarium, mixed osteoblastic/osteolytic lesions, and a hat that no longer fits (indicating progressive skull enlargement). 1

Most Likely Diagnosis: Paget's Disease of Bone

The clinical presentation is pathognomonic for Paget's disease:

  • Skull enlargement (hat no longer fits) is a hallmark feature of cranial involvement
  • Mixed osteoblastic/osteolytic lesions on skull imaging represent the characteristic radiological evolution of Paget's disease, where initial osteolytic lesions transform into mixed osteolytic-sclerotic bone 1
  • Thickened calvarium reflects the abnormal bone remodeling process
  • Headaches can result from skull involvement and increased bone turnover
  • Back pain suggests vertebral involvement, which is common in Paget's disease 1

Diagnostic Approach

Obtain plain radiographs of the skull and spine immediately to confirm the characteristic appearance of Paget's disease 1. The radiological findings should show:

  • Mixed osteolytic-sclerotic patterns in affected bones
  • Thickened cortices
  • Coarsened trabecular pattern

After radiological confirmation, measure serum total alkaline phosphatase (ALP) as the initial biochemical test 1. This is the most cost-effective marker and correlates well with disease extent and metabolic activity.

Critical Differential Diagnoses to Exclude

1. Malignancy (Highest Priority)

Must urgently exclude:

  • Osteosarcoma or other sarcomas - These arise in <1% of Paget's patients but represent a life-threatening complication, particularly in patients with multiple bone involvement 1
  • Metastatic disease - Can produce mixed lytic/blastic skull lesions
  • Multiple myeloma - Produces lytic lesions and can cause bone pain

Red flag: If the patient develops sudden, severe, localized pain in any affected bone, obtain urgent imaging to exclude sarcomatous transformation 1.

2. Metabolic Bone Diseases

  • Hyperparathyroidism - Can coexist with Paget's disease and should be considered, especially if hypercalcemia is present 1
  • Fibrous dysplasia - Can produce similar skull thickening but typically presents earlier in life

3. Other Skeletal Disorders

  • Fibrous dysplasia
  • Osteitis deformans variants

Important Clinical Pitfalls

Do not attribute all symptoms to the patient's known comorbidities (hypertension, hypothyroidism, BPH). While these conditions are common in this age group and can coexist 2, 3, 4, they do not explain the skull changes or mixed bone lesions.

Bone biopsy is rarely necessary - experienced clinicians can diagnose Paget's disease based on radiological and biochemical findings alone 1. Reserve biopsy only if malignancy cannot be excluded by other means.

Check for complications systematically:

  • Hearing loss - the most common neurological complication from cochlear damage 1
  • Cardiac assessment - cardiac output can increase with widespread active disease 1
  • Hypercalcemia - particularly if the patient becomes immobilized 1
  • Fracture risk - "chalk-stick" or "banana" fractures can occur through weakened pagetic bone 1

Next Steps After Diagnosis

If Paget's disease is confirmed:

  1. Assess disease extent with bone scintigraphy if multiple sites suspected
  2. Monitor ALP levels to guide treatment decisions
  3. Consider bisphosphonate therapy based on symptoms and biochemical activity
  4. Screen for complications including hearing loss and cardiac involvement

Related Questions

In an adult male with a history of bladder cancer and benign prostatic hyperplasia (BPH) who is currently taking tamsulosin, what is the recommended evaluation and management for new difficulty initiating his urine stream?
What complications should be anticipated when performing cystoscopy in a 78-year-old male with benign prostatic hyperplasia (BPH)?
In a man with symptomatic benign prostatic hyperplasia and a PSA within the age‑adjusted normal range, what is the appropriate management?
In a 71-year-old man with benign prostatic hyperplasia presenting with nocturia, weak urinary stream, mild PSA increase, hypertension, type 2 diabetes, hyperlipidemia, stage 3 chronic kidney disease on amlodipine, losartan, statin, and metformin, what is the recommended next step in management: start an alpha‑adrenergic blocker (tamsulosin) versus finasteride, oxybutynin, topical therapy, or referral for pelvic floor physical therapy?
What ICD‑10‑CM code should be assigned to a prostate MRI showing a 7 × 4 mm T2‑decreased signal focus in the right posterior medial mid‑peripheral zone suspicious for neoplastic disease and severe heterogeneous enlargement of the transition zone extending into the bladder base (suggestive of benign prostatic hyperplasia)?
What diagnosis should be documented for a patient with residual atrophy of the left lower extremity due to prior poliomyelitis?
In a 58-year-old man with hypertension, hypothyroidism, and benign prostatic hyperplasia who presents with headaches, back pain, frontal bossing, and skull X-ray showing thickened calvaria with mixed osteoblastic and osteolytic lesions, which serum findings are most likely (e.g., markedly elevated alkaline phosphatase with normal calcium and phosphate)?
Can iron deficiency anemia cause moderate splenomegaly?
Which test should be performed to evaluate testosterone levels?
What alternative lipid‑lowering options are available for a patient with familial hypercholesterolemia who experiences severe muscle weakness, cramping, and pain while taking evolocumab (Repatha)?
What is the appropriate Augmentin (amoxicillin/clavulanate) dosing regimen for acute bacterial sinusitis in adults, and how should it be adjusted for pediatric patients and those with renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.